Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link [email protected] to view the list of Journals that are available with us.
Q: How can I submit my paper?
The candidate can submit Manuscript in email to [email protected] or submit from the Journal Web page
Q: What is the time required to publish my paper?
Ans: The peer process will take a minimum of 30 business days. After peer revise process, it will be published within 3 days after acceptance of the paper.
Q: How can I join as Reviewer to this Journal?
Ans: You can write your interest in email to [email protected] and we will get back to you in 3-4 days.
Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.
Q: Whom do I have to contact at the Editorial office if I have any queries?
Ans: Kindly email your query to [email protected]. Editorial office or the respective Journal Managing Editor will respond you in 3-4 days.
Q: What is the eligibility if I would like to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned.
Q: Do you charge for a manuscript submission?
Ans: There are no charges for manuscript submission. The authors only need to pay the article processing charges once the article is accepted.
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.
Q: Why should an author pay the article processing charge?
In Open Access mode of publication, the scholarly literature will be made available to the researchers free of cost without any subscription charges. The whole maintenance of the operations i.e production of full text and PDF formats as well as archiving and indexing the published articles permanently through the article processing charges only. However, fee discounts will be provided to the authors from low income countries (According to World Bank classification).
Published : 11th September 2023
Mwanja Moses1,*, Lopwonya Fred2
Citation : Moses M, et al. (2023). Histopathological Patterns of Cervical Cancer among Females Presenting to a Pathology Core Reference Laboratory in Kampala, Uganda: A 5-Year Review. Mathews J Cancer Sci. 8(3):43.
Published : 04th September 2023
Authors : Luiz Eduardo Imbelloni1,*, Anna Lúcia Calaça Rivoli2, Sylvio Valença de Lemos Neto3, Ana Cristina Pinho3, Livia dos Santos Pereira4
Citation : Imbelloni LE, et al. (2023). Nephrectomy in an Infant during Intraoperative Cardiac Arrest, Requiring Prolonged Resuscitation. Case Report. Mathews J Cancer Sci. 8(3):42.
Published : 25th April 2023
Authors : Humberto Martínez-Cordero1,2,3,*, Luis Antonio Salazar2, Jair Figueroa2, Maria Isabel Arbeláez2, Alejandro Rico Mendoza3,4, Alexandra Porras Ramírez3,4,5, Henry Idrobo2, Viviana Olaya2, Kenny Gálvez2, Sergio Cancelado2, Juan Manuel Herrera2, Leonardo Bautista Toloza2, Jessica Zapata Malagón3, Lorena Cubillos Osorio3, Isabella Novoa-Caicedo3, On Behalf of GRIMMCO (Colombian Multiple Myeloma Research Group) and GRHEMUB (El Bosque University Hematology Group)
Citation : Martínez-Cordero H, et al. (2023). First Report of M-My Mind Study. Mathews J Cancer Sci. 8(2):41.
Published : 17th April 2023
Author : Pankaj Goyal*, Kishan Kumawat
Citation : Goyal P, et al. (2023). Upper Jaw Cancer: A Case Report of Surgical Intervention and Defect Repair in an Upper Alveolar Squamous Cell Carcinoma. Mathews J Cancer Sci. 8(2):39.
Published : 15th April 2023
Authors : Nisarg Hajariwala1,*, Prince Shah2, Prutha Patel2, Archi Desai2, Jaikumar Patel3
Citation : Hajariwala N, et al. (2023). A Case Report on Rituximab-induced Interstitial Lung Disease. Mathews J Cancer Sci. 8(2):40.
Published : 09th March 2023
Authors : M Ali1, Samreen Riaz2,*
Citation : Samreen R, et al. (2023). Cancer Treatment and Pharmacogenomics. Mathews J Cancer Sci. 8(1):38.